Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-CHOP in Elderly Patients With Untreated T-cell Angioimmunoblastic Lymphoma
NCT00169156Phase 2Completed
- Sponsor
- Lymphoma Study Association
- Start
- Dec 2005
- Primary completion
- Dec 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in angioimmunoblastic T-cell lymphoma (AITL), sponsored by Lymphoma Study Association. Started Dec 2005; status: completed.
02
Drugs
rituximab
03
Conditions
angioimmunoblastic T-cell lymphoma (AITL)
Beyond the preview
Go deeper on NCT00169156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00169156.